FZMD (Fuse Medical) EBIT: $3.87 Mil (TTM As of Jun. 2023)

What is Fuse Medical EBIT?

Fuse Medical FZMD 12 EBIT is $3.87 Mil as of Jun. 2023. GuruFocus rates FZMD with a GF Score™ of 12/100.

Fuse Medical's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2023 was $0.37 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was $3.87 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Fuse Medical's annualized ROC % for the quarter that ended in Jun. 2023 was 16.00%. Fuse Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 55.23%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Fuse Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 237.88%.

Fuse Medical (OTCPK:FZMD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Fuse Medical's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	1.476 * ( 1 - 2.22% )	/	( (8.815	+	9.222)	/ 2 )
=	1.4432328	/	9.0185
=	16.00 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	18.433	-	9.407	-	( 0.211	-	max(0, 11.287	-	12.241	+	0.211	))
=	8.815

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	19.318	-	9.843	-	( 0.253	-	max(0, 12.064	-	12.819	+	0.253	))
=	9.222

Note: The Operating Income data used here is four times the quarterly (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Fuse Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	1.476	/	( ( (0 + max(2.622, 0))	+	(0 + max(2.723, 0)) )	/	2 )
=	1.476	/	( ( 2.622	+	2.723 )	/	2 )
=	1.476	/	2.6725
=	55.23 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2.761	+	9.154	+	0.115)	-	(9.407	+	0	+	0.0010000000000012)
=	2.622

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(3.434	+	9.027	+	0.105)	-	(9.843	+	0	+	0)
=	2.723

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Fuse Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	3.868	/	1.626
	=	237.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuse Medical EBIT Related Terms

Fuse Medical EBIT Historical Data

* Premium members only.

The historical data trend for Fuse Medical's EBIT can be seen below:

Fuse Medical EBIT Chart

Fuse Medical Annual Data

Trend

Aug13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT

Get a 7-Day Free Trial

3.71

-2.41

-1.32

-1.49

3.29

Fuse Medical Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EBIT	Get a 7-Day Free Trial															-0.28	0.05	3.62	-0.17	0.37

FZMD vs GTHP, SONX, PBIO: EBIT Comparison

For the Medical Devices subindustry, Fuse Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fuse Medical EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fuse Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fuse Medical's EV-to-EBIT falls into.

Save Embed

12GF Score

Fuse Medical Inc FZMD

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Fuse Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.87 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of $3.87 Mil mean?

Fuse Medical (FZMD) has a EBIT of $3.87 Mil as of Jun. 2023. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Fuse Medical.

Is Fuse Medical's EBIT too high?

Fuse Medical's current EBIT is $3.87 Mil. Overall, Fuse Medical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Fuse Medical's EBIT compare to GTHP and SONX?

Fuse Medical's EBIT of $3.87 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Medical Devices & Instruments company?

A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Fuse Medical. Fuse Medical's current EBIT is $3.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Fuse Medical stock overvalued right now?

Fuse Medical (FZMD) has a current EBIT of $3.87 Mil. The current EBIT is $3.87 Mil. Fuse Medical's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For Fuse Medical (FZMD), the current EBIT is $3.87 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fuse Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies GTHP SONX PBIO TBIO BIOL AIMD QLIS VVOS VAPO CMXC ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH

Address 4343 Sigma Road, Suite 500, Farmers Branch, TX, USA, 75244

Website https://www.fusemedical.com

Fuse Medical Inc is a manufacturer, distributor, and wholesaler of medical device implants, offering portfolio of orthopedic implants and biologics including: internal fixation products, upper and lower extremity plating and total joint reconstruction implants, soft tissue fixation and augmentation for sports medicine procedures, spinal implants for trauma, degenerative disc disease and deformity indications, and osteo-biologics, regenerative and connective tissues, which include human allografts, substitute bone materials, tendons, and regenerative tissues. Its portfolio of Orthopedic Implants and Biologics provide products to assist surgeons with positive patient outcomes and cost-effective solutions for its customers including hospitals, medical facilities, and sub-distributors.

12GF Score

Get the complete analysis for FZMD

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02

Price

View FZMD Analysis

See EBIT data for all stocks →